Company News
Catalyst Pharma Up 5% on Angelini Takeover
Catalyst Pharmaceuticals shares rose 5% on Monday after Bloomberg reported Angelini Pharma is exploring a potential acquisition.
Angelini Pharma, a family‑owned Italian drugmaker, is working with advi
